# US 2025/0082602 A1 · Ophthalmic composition containing recoflavone for the treatment of dry eye disease

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082602 A1
- Document ID: US20250082602A1
- Status: Published application
- Kind: A1
- Application number: 18/562,299
- Filed: 2022-08-04
- Published: 2025-03-13
- Earliest claimed: 2021-08-05
- Assignees: Gl Pharmtech Corp.
- Applicants: Gl Pharmtech Corp.
- Inventors: Eun Jung KIM; Jun Sang PARK
- Web page: https://patentgrep.com/patent/US20250082602A1

## CPC

- A61K 31/353: 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61P 27/02: Ophthalmic agents
- A61K 9/0048: {Eye, e.g. artificial tears}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 31/352: condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)}
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/186: {Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide}
- A61K 47/32: Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone}
- A61K 47/38: Cellulose; Derivatives thereof
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- A61P 27/04: Artificial tears; Irrigation solutions
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to an ophthalmic composition containing recoflavone for the treatment of dry eye disease. Specifically, in order to maximize the improvement of symptoms of dry eye, the present invention relates to an ophthalmic composition containing a certain concentration of the active ingredient and at least one of polyoxyethylene castor oil derivatives or poloxamers which are permeation enhancers, so that the active ingredient, recoflavone, can sufficiently penetrate the cornea in vivo to exhibit significant therapeutic effects.

## Claims

### Claim 1

An ophthalmic composition for the treatment of dry eye disease, the composition comprising 5% (w/v) or more of recoflavone or a pharmaceutically acceptable salt thereof; and 0.1 to 5.0% (w/v) of polyoxyethylene castor oil derivative or poloxamer alone or in combination.

### Claim 2 (depends on 1)

The ophthalmic composition for the treatment of dry eye disease of claim 1, wherein the polyoxyethylene castor oil derivative is polyoxyl 35 castor oil.

### Claim 3 (depends on 1)

The ophthalmic composition for the treatment of dry eye disease of claim 1, wherein the poloxamer is poloxamer 407.

### Claim 4 (depends on 1)

The ophthalmic composition for the treatment of dry eye disease of claim 1, wherein the ophthalmic composition for the treatment of dry eye disease comprises 5% (w/v) to 10% (w/v) of recoflavone or a pharmaceutically acceptable salt thereof.

### Claim 5 (depends on 1)

The ophthalmic composition for the treatment of dry eye disease of claim 1, wherein the ophthalmic composition for the treatment of dry eye disease has a pH range from 5.0 to 7.0.
